Bosun S. Hau
Bosun is a Managing Director and Partner at Sailing Capital in Hong Kong, a global private equity firm leveraging unique government and corporate relationships in China. He has nearly 15 years of healthcare industry experience, primarily as an investor in both private and publicly-listed companies.
Prior to joining Sailing in 2015, Bosun was a Partner at MVM Life Science Partners in Boston and London. Previously, he was a sell-side equity analyst covering medical technology and pharmaceuticals for JP Morgan Securities In New York. He also has experience as a management consultant with McKinsey & Company in Southeast Asia and as an early stage VC investor with S.R. One, GlaxoSmithKline’s corporate venture group. He began his career at Eli Lilly & Company in sales and marketing.
Bosun is currently, or has been, a Board Director for many emerging and leading healthcare companies. He also is a Board Overseer of Beth Israel Deaconess Medical Center in Boston, a major teaching hospital of Harvard Medical School.
Bosun holds an MBA from the Wharton School at the University of Pennsylvania and a Master’s Degree in Biotechnology from Johns Hopkins University. He is a triple-bachelor’s degree recipient from the University of Arizona.